文献速递肿瘤 PET/CT甲状腺核医学心脏核医学

分化型甲状腺癌持续TSH抑制期间血管炎症的纵向[18F]FDG PET/CT分析

Assessing vascular inflammation during continuous TSH suppression in differentiated thyroid cancer: a longitudinal [18F]FDG PET/CT analysis.
PubMed 文献 · EJNMMI Res · 2026-04-14

该回顾性研究分析了51例分化型甲状腺癌患者,在持续TSH抑制下进行两次[18F]FDG PET/CT扫描,间隔4.6±4.2年。结果显示颈动脉和主动脉弓的FDG摄取(TBRmax)在随访时显著升高,所有动脉节段的钙化斑块评分也明显增加,但FDG摄取与扫描间隔无显著相关,提示非线性重塑而非炎症持续加重。

要点

  • 持续TSH抑制与颈动脉和主动脉弓FDG摄取轻度增加相关
  • 所有动脉节段钙化斑块评分在随访时显著升高,且与扫描间隔中度相关
  • FDG摄取与钙化斑块评分呈弱且不显著的负相关趋势(p=0.09)

核心结论

  • 持续TSH抑制与特定部位动脉FDG摄取轻度增加相关,FDG摄取与扫描间隔无显著相关,提示非线性重塑而非炎症持续加重。

研究设计与样本

  • 回顾性分析51例分化型甲状腺癌患者,均在甲状腺切除和放射性碘消融后持续TSH抑制下进行两次[18F]FDG PET/CT,间隔4.6±4.2年。

主要发现

  • 随访PET/CT中颈动脉和主动脉弓的TBRmax显著高于基线(颈动脉:1.55±0.28 vs. 1.39±0.29;主动脉弓:1.78±0.31 vs. 1.65±0.28;均p<0.05)。
  • 升主动脉、降主动脉和腹主动脉的FDG摄取无显著差异,所有动脉节段合并分析亦无显著差异(均p>0.05)。
  • 所有动脉部位的钙化斑块评分在随访时显著升高,且与扫描间隔中度相关(p<0.05)。
  • FDG摄取与钙化斑块评分呈弱且不显著的负相关趋势(p=0.09)。

关键数值与推荐

  • 颈动脉TBRmax基线1.39±0.29,随访1.55±0.28(p<0.05)。
  • 主动脉弓TBRmax基线1.65±0.28,随访1.78±0.31(p<0.05)。
  • 钙化斑块评分随访时在所有动脉均显著升高,与扫描间隔中度相关(p<0.05)。

临床怎么用

  • 对持续TSH抑制的分化型甲状腺癌患者,可考虑心血管风险评估和个体化TSH抑制策略。

局限性

  • 回顾性设计,样本量51例,需前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thyroid hormone imbalance has been linked to cardiovascular effects, including atrial fibrillation and cardiac hypertrophy. More recently, studies also suggest higher arterial inflammation during TSH-suppressive therapy. We therefore examined whether continuous TSH suppression is associated with longitudinal increases in arterial inflammation and progression of vascular calcification. RESULTS: We retrospectively analyzed 51 patients with differentiated thyroid cancer who underwent two [18F]FDG PET/CT scans, both performed under continuous TSH suppression, after initial treatment with thyroidectomy and radioiodine ablation. The interval between scans was 4.6 ± 4.2 years. A region of interest (ROI) was placed in the carotid artery, aortic arch, ascending-, descending-, and abdominal aorta to extract standard uptake values (SUVs). Blood pool activity of the superior cava vein was used for target-to-background ratio (TBR). We found that FDG uptake (TBRmax) was higher on the follow-up PET/CT in the carotid arteries and aortic arch (mean TBRmax ± SD: 1.55 ± 0.28, 1.78 ± 0.31 vs. 1.39 ± 0.29, 1.65 ± 0.28, respectively; both p < 0.05). No significant differences were seen in the ascending-, descending-, or abdominal aorta, nor when all arterial segments were combined (all p > 0.05). No relevant correlation was observed between interscan interval and TBRmax. Additionally, calcified plaque (CP) scores were derived from the CT component for each arterial site. CP score was markedly higher at follow-up scan in all arteries and correlated moderately with the interscan interval (p < 0.05). A weak, non-significant inverse trend was found between FDG uptake and CP score (p = 0.09). CONCLUSIONS: Continuous TSH suppression was associated with modest increases in arterial FDG uptake at certain sites. The lack of a significant correlation between interscan interval and FDG uptake suggests non-linear remodeling rather than steadily increasing inflammation. These findings highlight the need for prospective studies and suggest that individualized TSH suppression strategies, along with cardiovascular risk assessment, may be warranted.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Einspieler H, Hennig B, Klimpfinger H, et al. Assessing vascular inflammation during continuous TSH suppression in differentiated thyroid cancer: a longitudinal [18F]FDG PET/CT analysis. EJNMMI Res. 2026. PMID: 41979698. doi:10.1186/s13550-026-01414-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。